SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
程南
Lv2
190 积分
2023-03-30 加入
最近求助
最近应助
互助留言
Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study
8天前
已完结
New Prospective Cohort Study and Mendelian Randomization Analysis Reveals a Link Between Psoriasis and Cardiovascular Risk Trough Elevated Plasma Triglycerides
12天前
已完结
Nonclinical safety of tildrakizumab, a humanized anti–IL-23p19 monoclonal antibody, in nonhuman primates
12天前
已完结
Outcomes of pregnancies from the tildrakizumab phase I–III clinical development programme
12天前
已完结
Investigating the risk of deep vein thrombosis with JAK inhibitors: a disproportionality analysis using FDA Adverse Event Reporting System Database (FAERS)
13天前
已完结
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real‐world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group
13天前
已完结
Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris
14天前
已完结
Coesisting inflammatory skin diseases: Tildrakizumab to control psoriasis and omalizumab for urticaria
14天前
已完结
Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis
14天前
已完结
Short-Term Cardiovascular Complications in Dermatology Patients Receiving JAK-STAT Inhibitors A Meta-Analysis of Randomized Clinical Trials
16天前
已完结
没有进行任何应助
已找到【积分已退回】
14天前
已找到【积分已退回】
14天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论